HRP20191173T1 - Postupak za proizvodnju derivata hidroksietil škroba - Google Patents

Postupak za proizvodnju derivata hidroksietil škroba Download PDF

Info

Publication number
HRP20191173T1
HRP20191173T1 HRP20191173TT HRP20191173T HRP20191173T1 HR P20191173 T1 HRP20191173 T1 HR P20191173T1 HR P20191173T T HRP20191173T T HR P20191173TT HR P20191173 T HRP20191173 T HR P20191173T HR P20191173 T1 HRP20191173 T1 HR P20191173T1
Authority
HR
Croatia
Prior art keywords
temperature
value
solution
adjusting
heating
Prior art date
Application number
HRP20191173TT
Other languages
English (en)
Croatian (hr)
Inventor
Werner Zimmermann
Jan Lukowczyk
Original Assignee
Serumwerk Bernburg Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44799422&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20191173(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serumwerk Bernburg Ag filed Critical Serumwerk Bernburg Ag
Publication of HRP20191173T1 publication Critical patent/HRP20191173T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/08Ethers
    • C08B31/12Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/08Ethers
    • C08B31/10Alkyl or cycloalkyl ethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/18Oxidised starch
    • C08B31/185Derivatives of oxidised starch, e.g. crosslinked oxidised starch

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HRP20191173TT 2011-06-21 2012-06-21 Postupak za proizvodnju derivata hidroksietil škroba HRP20191173T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11170761A EP2537866A1 (en) 2011-06-21 2011-06-21 Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof
PCT/EP2012/061958 WO2012175608A1 (en) 2011-06-21 2012-06-21 Method for manufacturing hydroxyethyl starch derivatives
EP12737229.0A EP2723774B1 (en) 2011-06-21 2012-06-21 Method for manufacturing hydroxyethyl starch derivatives

Publications (1)

Publication Number Publication Date
HRP20191173T1 true HRP20191173T1 (hr) 2019-10-04

Family

ID=44799422

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20191173TT HRP20191173T1 (hr) 2011-06-21 2012-06-21 Postupak za proizvodnju derivata hidroksietil škroba

Country Status (22)

Country Link
US (2) US9181353B2 (enExample)
EP (2) EP2537866A1 (enExample)
JP (2) JP6370217B2 (enExample)
CN (2) CN105348401A (enExample)
BR (1) BR112013032901A2 (enExample)
CA (1) CA2837784C (enExample)
CY (1) CY1121976T1 (enExample)
DK (1) DK2723774T3 (enExample)
ES (1) ES2733767T3 (enExample)
HK (1) HK1220218A1 (enExample)
HR (1) HRP20191173T1 (enExample)
HU (1) HUE044428T2 (enExample)
LT (1) LT2723774T (enExample)
MX (1) MX337682B (enExample)
PL (1) PL2723774T3 (enExample)
PT (1) PT2723774T (enExample)
RS (1) RS59021B1 (enExample)
SI (1) SI2723774T1 (enExample)
SM (1) SMT201900430T1 (enExample)
TR (1) TR201909574T4 (enExample)
TW (1) TWI564010B (enExample)
WO (1) WO2012175608A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6616725B2 (ja) * 2016-03-31 2019-12-04 日本製紙株式会社 塗工紙用澱粉
SG11202107050RA (en) 2019-01-10 2021-07-29 Pharmacosmos Holding As Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillation
EA202191858A1 (ru) 2019-06-12 2021-11-12 Фармакосмос Холдинг А/С Лечение дефицита железа у субъектов с риском нежелательных явлений со стороны сердечно-сосудистой системы и железо для лечения фибрилляции предсердий
CA3226771A1 (en) 2021-08-03 2023-02-09 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
CN117547549A (zh) * 2023-11-09 2024-02-13 黑龙江八一农垦大学 适用于犬arf的腹膜透析液与助清除剂的制备方法
WO2026017901A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in neurodevelopmental or psychiatric disorder

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639588A (en) * 1966-10-22 1972-02-01 Fisons Pharmaceuticals Ltd Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids
US4370476A (en) * 1979-07-17 1983-01-25 Usher Thomas C Dextran polycarboxylic acids, ferric hydroxide complexes
GB8902894D0 (en) * 1989-02-09 1989-03-30 Fisons Plc Compositions
JPH0566372A (ja) * 1991-09-10 1993-03-19 Fukui Megane Kogyo Kk 金属製眼鏡フレーム部品の製造方法
JPH0776524A (ja) * 1993-07-13 1995-03-20 Takeda Chem Ind Ltd 動物用抗貧血剤
DK172860B1 (da) 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DK173138B1 (da) 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
EP1762250A1 (en) 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine
JP5178836B2 (ja) * 2007-08-17 2013-04-10 アクゾ ノーベル ナムローゼ フェンノートシャップ グルタミン酸n,n−二酢酸のアルカリ金属塩、そのような塩の調製プロセス及びその使用
TWI469965B (zh) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
JP5397991B2 (ja) * 2009-04-01 2014-01-22 学校法人東京農業大学 乳酸菌を用いたビタミンb12の定量方法

Also Published As

Publication number Publication date
CA2837784A1 (en) 2012-12-27
US20140128594A1 (en) 2014-05-08
JP6370217B2 (ja) 2018-08-08
DK2723774T3 (da) 2019-07-15
TWI564010B (zh) 2017-01-01
CN103649128B (zh) 2016-02-10
BR112013032901A2 (pt) 2017-01-24
MX2013015075A (es) 2014-04-14
SMT201900430T1 (it) 2019-09-09
CA2837784C (en) 2019-10-15
ES2733767T3 (es) 2019-12-02
RS59021B1 (sr) 2019-08-30
WO2012175608A1 (en) 2012-12-27
PT2723774T (pt) 2019-07-15
LT2723774T (lt) 2019-08-12
US20160046733A1 (en) 2016-02-18
TR201909574T4 (en) 2019-08-21
CN103649128A (zh) 2014-03-19
SI2723774T1 (sl) 2019-08-30
MX337682B (es) 2016-03-15
EP2537866A1 (en) 2012-12-26
EP2723774A1 (en) 2014-04-30
JP2014520188A (ja) 2014-08-21
JP2018100424A (ja) 2018-06-28
HUE044428T2 (hu) 2019-10-28
CN105348401A (zh) 2016-02-24
US9631032B2 (en) 2017-04-25
HK1220218A1 (zh) 2017-04-28
CY1121976T1 (el) 2020-10-14
PL2723774T3 (pl) 2019-10-31
US9181353B2 (en) 2015-11-10
TW201315474A (zh) 2013-04-16
EP2723774B1 (en) 2019-04-03

Similar Documents

Publication Publication Date Title
HRP20191173T1 (hr) Postupak za proizvodnju derivata hidroksietil škroba
MX2019008014A (es) Metodo para aumentar la solubilidad de rebaudiosido d en agua.
ME02177B (me) Supstituisani derivati ksantina
WO2010148463A8 (en) Metal organic framework synthesis
JP2014125461A5 (enExample)
JP2014520188A5 (enExample)
CN105254688A (zh) 一种硫酸异帕米星(ⅰ)的制备方法
FR2972452B1 (fr) Procede de preparation du difluoroacetonitrile et de ses derives
JP2011052284A5 (enExample)
TW201612213A (en) Polyamide ester resin, method for preparing the same, and molded article including the same
HRP20210966T1 (hr) Sinteza trans-8-kloro-5-metil-1-[4-(piridin-2-iloksi)-cikloheksil]-5,6-dihidro-4h-2,3,5,10b-tetraaza­benzo[e]azulena i njegovih kristalnih oblika
JP2009523791A5 (enExample)
CA2796770A1 (en) Process for preparing pa-4x, and pa-410 obtainable by the process
WO2011052987A3 (ko) 식각액 조성물
HRP20200365T1 (hr) Postupak povećavanja brzine nastajanja produkta reakcije karboksilne kiseline s ureom dodavanjem kiseline
JP2015071530A5 (enExample)
JP2010285408A5 (enExample)
JP2014001364A5 (enExample)
JP2012140392A5 (enExample)
PH12016500261A1 (en) Nanoparticles and nanoparticle composition, and method for producing nanoparticles and nanoparticle composition
TN2014000527A1 (en) Free flowing salt composition prepared by evaporative crystallization
DK2034054T3 (da) Fremgangsmåde til fremstilling af en belagt komponent til fluidumførende enheder og belagt komponent
PL385669A1 (pl) Sposób wytwarzania pręta o teksturze osiowej <001> ze stopów na osnowie faz Heuslera wykazujących magnetyczną pamięć kształtu
MX2012011246A (es) Interconversion entre acidos p-mentan-3-carboxilicos isomericos.
CN104987308A (zh) 一种5-溴-2-吡啶甲酸的制备方法